Skip to main content

Genes for Low Glycemic Index

Researchers identify genes for low glycemic index and high protein in rice

A team of researchers at the International Rice Research Institute (IRRI) has identified genes and markers responsible for low glycemic index (GI) and high protein content in rice, using genetics and artificial intelligence classification methods.

Their study, recently published in the Proceedings of the National Academy of Sciences, revealed a superior set of lines that exhibited ultra-low GI (below 45%) with an unprecedented protein level (15.99), which is twice the content usually found in conventional milled rice. Rice varieties with higher protein content may contribute to slower digestion and absorption rates, potentially helping control blood glucose levels, further enhancing its ultra-low GI characteristics.

"Collectively, these findings underscore the stacked potential and benefits of low GI and high protein rice to offer a substantial source of protein and essential amino acids such as lysine for consumers, particularly in regions where rice is a dietary staple," said Dr. Nese Sreenivasulu, corresponding author of the paper and Principal Scientist at the IRRI Grain Quality and Nutrition Center. He adds that the lines included in the study also generated yields comparable to existing high-yielding rice varieties.

The healthier rice lines were developed by intercrossing an inbred variety from Samba Mahsuri and the amylose extender of IR36. The results could help address the growing incidence of diabetes and the need for adequate protein intake for hundreds of millions of people at risk.

Globally, about 537 million adults suffer from diabetes, and the number is expected to grow to 783 million by 2045. Low- and middle-income countries account for more than three-quarters of diabetes incidences, with Asia accounting for 60% of the global diabetic population. High-protein rice may help boost the diets and health of half a billion protein-deficient consumers, many of whom live in South Asia and Central Africa.

"Considering that rice is a staple food for a substantial portion of the global population, it is crucial to deploy high-yielding rice cultivars with milled rice samples possessing high-quality protein and ultra-low glycemic index to address the triple burden of nutritional challenges among low- and middle-income communities," said Dr. Gurdev S. Khush of the University of California, Davis, and co-corresponding author of the paper.

Dr. Sreenivasulu's team and partners now seek to incorporate these genes into future breeding programs and popular varieties grown across Asia and Africa.

"With its remarkably low GI and protein content surpassing traditional rice varieties, these high-yielding nutritious rice varieties will pave the way to addressing critical food and nutritional security targets," said IRRI Director General Dr. Yvonne Pinto.

The study was conducted in collaboration with the University of California, Davis, the United States of America, the Max Planck Institute of Molecular Plant Physiology in Germany, and the Center of Plant Systems Biology in Bulgaria.


Glycemic control
Insulin sensitivity
Glucose metabolism
Glycemic response
Type 2 diabetes
Nutrigenomics
Genetic predisposition
Dietary carbohydrates
Blood sugar regulation
SLC2A2 gene
TCF7L2 gene
GCK gene
FTO gene
PPARG gene
GIPR gene
IRS1 gene
ADIPOQ gene
Beta-cell function
SNP variants
Metabolic syndrome

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 
facebook.com/profile.php?id=61555903296992 
tumblr.com/blog/dorita0211 

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...